ASPYRA PACS Receives CE Mark
Jacksonville, FL — February 2, 2017, ASPYRA, LLC (ASPYRA), a market leader in Picture Archive and Communication Systems (PACS), announced today that they have received the CE Mark on their PACS products including MedVIEW with AccessNET. The company’s PACS products were evaluated by BSI Group (notified body number 0086) to validate that the products and processes used meet the requirements for CE mark. The CE mark is a quality certification widely used in the EU marketplace.
CE mark requirements cover every aspect of the product including planning and development, risk management, service, labeling, complaint handling, customer communication, and reporting of any adverse events among other requirements. The validation process involves third party audits of the company’s internal practices and policies, documentation, and verification that appropriate European and US standards are being followed.
“ASPYRA has always followed standards including ISO 13485, ISO 14971:2012 for Risk Management, and USA Federal regulations such as the 21 CFR 820 and others from the FDA, HHS, et al” states Gary Bennett, ASPYRA President. “The CE mark checks against additional standards such as Medical Device Directive 93/42/EEC, MEDDEV 2.12-1 (Medical Devices Vigilance System), and EN62304:2006 (Medical Device Software Life Cycle). The CE Mark is a valuable tool for customers, particularly in conjunction with the ISO 13485 certification, giving them the utmost confidence that our products are made to the highest quality standards.”
About The Company
ASPYRA is a privately held, global, software company specializing in PACS and Laboratory Information Systems. ASPYRA is recognized for providing flexible, engineered workflow solutions that include software, interfaces, and professional services to hospitals, clinics, specialty labs, reference labs, imaging centers and orthopedic practices worldwide. We form long-term relationships with our customers and provide software solutions that support their efforts so they can better care for their patients and community. If you would like to view a PDF version, please email jwallace@aspyra.com.